Trials / Completed
CompletedNCT06129513
The Effect of a Plant-blend Protein Isolate on Post-exercise Myofibrillar Protein Synthesis
The Effect of a Novel Plant-blend Protein Isolate on Post-exercise Myofibrillar Protein Synthesis When Compared to Whey Protein in Healthy Young Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of Exeter · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Dietary protein ingestion is required to maximise the anabolic response during the recovery from resistance exercise. Whey protein is considered the optimal dietary strategy to maximise post-exercise muscle protein synthesis, but animal-protein production and consumption is associated with growing environmental and ethical concerns. Plant-based protein sources are considered of lesser anabolic quality than isonitrogenous boluses of animal-derived protein attributed to, at least in part, deficiencies in key essential amino acid. Blending different protein sources may overcome amino acid deficiencies and potentiate the post-exercise anabolic response. In the present study the investigators assessed the post-exercise muscle protein synthetic response following the ingestion of a novel plant-based protein isolate when compared with an isonitrogenous bolus of whey protein in healthy young, resistance trained women and men.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Bilateral resistance exercise | A bout of bilateral resistance exercise consisting of barbell back squat, leg leg press and leg extension |
| DIETARY_SUPPLEMENT | Whey protein | Following execution of bilateral resistance exercise, participants will ingest 32 g protein from whey protein isolate |
| DIETARY_SUPPLEMENT | Plant-blend protein | Following execution of bilateral resistance exercise, participants will ingest 32 g protein from plant-blend protein isolate |
Timeline
- Start date
- 2022-02-24
- Primary completion
- 2022-10-31
- Completion
- 2022-10-31
- First posted
- 2023-11-13
- Last updated
- 2023-11-13
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06129513. Inclusion in this directory is not an endorsement.